PAMED NEWS

On June 5, 2025, the U.S. Food & Drug Administration (FDA) granted De Novo authorization to Clairity Breast, the first-ever AI-powered platform that predicts a woman’s risk of developing breast cancer over the next five years—using only a standard mammogram. De Novo authorization is especially meaningful as it marks the very first platform of its kind.

Effective July 1, 2025, AmeriTrust Group, Inc., an affiliate brand of AF Group, will no longer directly service Pennsylvania Medical Society members. To better support the association members, we have appointed World Insurance Associates LLC as the exclusive agent for brokerage services -- AmeriTrust will remain the insurance carrier.

The United States Supreme Court, on June 23, 2025, denied the petition of the Pennsylvania Joint Underwriting Association (JUA) to have the Supreme Court review its case against Governor Shapiro and the Commonwealth of Pennsylvania.

Addition of Metachromatic Leukodystrophy to the Supplemental Conditions Mandated for Screening in this Commonwealth

The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public on the following:

Extreme heat is forecasted for Pennsylvania starting Sunday, June 22 and continuing into early next week.

The U.S. Supreme Court has upheld a Tennessee state statute that banned certain medical interventions for minors for purposes of attempting to change sexual identity or to address discomfort with sexual identity. In United States v. Skrmetti, by a 6-3 vote, the Court on June 18, 2025, determined that constitutional review of the state law did not require higher-level legal scrutiny and that the state law met the applicable legal standard for constitutionality.

Delegation Chair and Vice Chair, Jill Owens, MD and John Vasudevan, MD, led twenty-eight members of the Pennsylvania Delegation to the American Medical Association (AMA) at the Annual Meeting of the AMA House of Delegates (HOD or the House) in Chicago from June 6 – 11, 2025.

The Pennsylvania Department of Health (DOH) is forwarding the following advisory to health care providers, “Responding to Overdose and Withdrawal Involving Medetomidine” from the Philadelphia Department of Public Health (PDPH).

The Department of Human Services (Department) announces changes to the Medical Assistance (MA) Program Fee Schedule. These changes are effective for dates of service on and after June 16, 2025.

The Department of Human Services is announcing its intent to increase the funding for a class of disproportionate share hospital payments to qualifying hospitals for Fiscal Year 2024-2025.

The Secretary of Health of the Department of Health is publishing this notice of intent to issue a final notice to temporarily schedule any material, compound, mixture or preparation which contains any quantity of certain Nitazene substances, their salts, isomers and salts of isomers.

Introduced by Representative Lisa Borowski (D-Delaware), House Bill 1460 aims to strengthen oversight of major healthcare transactions involving private equity and large health systems.

The State Board of Osteopathic Medicine (board) has discovered the text of § 25.241(5.1) was inadvertently omitted when amendments to § 25.241 were published in the January 18, 2025, edition of the Pennsylvania Bulletin (55 Pa.B. 457).

The Preventative Health and Health Services Block Grant Advisory Committee will hold a public meeting on Tuesday, June 17, 2025 to present the Federal Fiscal Year 2025 Workplan and budget information.

On April 24, 2025, the Centers for Medicare & Medicaid Services approved the Commonwealth's application for an extension of its 1332 State Innovation Waiver under the Affordable Care Act (ACA) for an additional 5 years.

PAMED’s annual House of Delegates (HOD) meeting has long served as a platform for physicians to make their voices heard, shaping policies that influence the practice of medicine in Pennsylvania.

The Pharmaceutical Assistance Advisory Board will hold a meeting by means of Microsoft Teams on Monday, June 16, 2025, from 1 p.m. to 2:30 p.m.

The Patient Safety Authority (Authority) announces a meeting of the Authority's Board to be held virtually by means of the Authority's webinar platform Zoom on Tuesday, June 17, 2025, at 1 p.m. and is open to the general public.

The temporary scheduling of any material, compound, mixture or preparation which contains any quantity of certain Nitazene substances, their salts, isomers and salts of isomers will expire on June 3, 2025.